Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approach

1 Dec 2020

Abstract excerpt

The coronavirus disease 19 (COVID-19) is a highly contagious and rapidly spreading infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In some cases, the disease can be fatal which resulted in more than one million deaths worldwide according the WHO. Currently, there is no effective vaccine or treatment for COVID-19, however many small-molecule inhibitors have shown potent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Peptides and Activities
Share to Computational Drug Discovery Methods
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33364503
DOI: 10.1016/j.heliyon.2020.e05739

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approachPMID 33364503Read ↗

CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 variantsSemantic proximity Read ↗

Molecular docking and dynamic simulation of conserved B cell epitope of SARS-CoV-2 glycoprotein Indonesian isolates: an immunoinformatic approachSemantic proximity Read ↗

Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26Semantic proximity Read ↗

Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics ApproachesSemantic proximity Read ↗

In Silico Discovery and Evaluation of Inhibitors of the SARS-CoV-2 Spike Protein–HSPA8 Complex Towards Developing COVID-19 Therapeutic DrugsSemantic proximity Read ↗

Structural Comparison and Drug Screening of Spike Proteins of Ten SARS-CoV-2 VariantsSemantic proximity Read ↗

Antiviral Peptides as Promising Therapeutics against SARS-CoV-2Semantic proximity Read ↗

Identification of a Druggable Site on GRP78 at the GRP78-SARS-CoV-2 Interface and Compounds to Disrupt that InterfaceSemantic proximity Read ↗

Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural DataSemantic proximity Read ↗

Immunoinformatics study to search epitopes of spike glycoprotein from SARS-CoV-2 as potential vaccineSemantic proximity Read ↗

Immunoinformatics-Guided Designing of an Epitope-Based Vaccine against Severe Acute Respiratory Syndrome-Coronavirus-2 Spike GlycoproteinSemantic proximity Read ↗

Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike proteinSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.